Related Experiment Videos
Effect of screening algorithm, parameter values and median smoothing on patient-specific risk estimates for Down's
K L Williams1, B A Nix, F D Dunstan
1Department of Medical Computing and Statistics, University of Wales College of Medicine, Cardiff, UK. williamsKL2@cardiff.ac.uk
Annals of Clinical Biochemistry
|March 29, 2000
Summary
Screening programs for Down's syndrome may appear equivalent at a population level but can significantly differ for individual patients. Variations in algorithms and parameters lead to diverse risk calculations and patient management decisions.
Area of Science:
- Prenatal screening
- Maternal serum screening
- Down's syndrome risk assessment
Background:
- Down's syndrome screening efficiency is typically measured by detection and false positive rates.
- Equivalent population-level performance may mask significant individual patient-level discrepancies.
Purpose of the Study:
- To investigate how variations in screening algorithms and parameter estimations affect individual Down's syndrome risk calculations.
- To determine if these variations explain the range of risks reported in national quality assessment schemes.
Main Methods:
- Analysis of different algorithms and parameter values used in Down's syndrome screening.
- Evaluation of alternative methods for estimating gestational age-dependent marker medians.
- Comparison of risk calculations across different screening program implementations.
Main Results:
- Different algorithms and parameter choices yield substantially different individual risk assessments.
- Even with similar population-level metrics, the specific women identified for further testing can vary greatly.
- Variations in methodology contribute significantly to the observed range of Down's syndrome risks in quality assessments.
Conclusions:
- Down's syndrome screening programs with similar overall efficiency metrics are not necessarily equivalent at the individual patient level.
- Standardization of algorithms and parameter estimation is crucial for consistent and reliable individual risk assessment.
- Understanding these methodological differences is key to interpreting and improving the accuracy of prenatal Down's syndrome screening.